MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
Prnewswire·2025-08-13 11:30
MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products. MediPharm is the only US FDA Audited purpose-built commercial cannabis facility in Canada. One of a handful globally. The possible rescheduling of cannabis in the US opens new opportunities for MediPharm in categories where the Company maintains a competitive advantage.TORONTO, Aug. 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (O ...